Investigating how certain receptors affect high blood pressure

Inflammatory Nicotinic Acetylcholine Receptors in a Genetic Model of Essential Hypertension

['FUNDING_OTHER'] · IOWA CITY VA MEDICAL CENTER · NIH-10948084

This study is looking at how certain receptors in the body might play a role in high blood pressure, which affects many adults, to help find new ways to treat it in the future.

Quick facts

Phase['FUNDING_OTHER']
Study typeNih_funding
SexAll
SponsorIOWA CITY VA MEDICAL CENTER (nih funded)
Locations1 site (IOWA CITY, UNITED STATES)
Trial IDNIH-10948084 on ClinicalTrials.gov

What this research studies

This research explores the role of nicotinic acetylcholine receptors in the development of essential hypertension, a condition affecting nearly half of US adults. By studying a genetic model of hypertension, the researchers aim to understand how the nervous and immune systems interact and contribute to high blood pressure. The approach involves identifying specific receptors and their inflammatory responses, which could lead to new therapeutic strategies for managing hypertension. Patients may benefit from insights that could inform future treatments targeting these receptors.

Who could benefit from this research

Good fit: Ideal candidates for this research are adults over 21 years old who are experiencing hypertension or are at risk for developing it.

Not a fit: Patients with hypertension caused by non-genetic factors or those under 21 years old may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new therapies for managing high blood pressure, improving health outcomes for millions of patients.

How similar studies have performed: Other research has shown promising results in understanding the neuro-immune interactions in hypertension, suggesting that this approach could yield valuable insights.

Where this research is happening

IOWA CITY, UNITED STATES

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.

View on NIH RePORTER →

Last reviewed 2026-05-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.